Searched for

MIRATI SHAREHOLDERS

France's Sanofi to buy US drugs project INBRX-101 for about $2.2 billion
French healthcare company Sanofi has agreed to buy drug development project INBRX-101 from parent company Inhibrx Inc for $2.2 billion. INB...
23 Jan, 2024, 02.16 PM IST
Bristol Myers to buy Mirati for $4.8 billion
The purchase will give a boost to Bristol as patent expirations weigh on sales of its oncology medicines. The company had to slash its reve...
09 Oct, 2023, 11.43 PM IST

Hot on Web